Kirkland represents GTCR and Corza Health, Inc., on the acquisition of TachoSil® Fibrin Sealant Patch from Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK). Corza Health was formed in 2019 as a partnership between private equity firm GTCR and healthcare industry veteran Gregory T. Lucier to build a market-leading healthcare business with a particular focus on the broader medical technology and life sciences sector. Takeda will receive €350 million in cash upon closing of the transaction, which is subject to customary legal and regulatory closing conditions.
Read the press release from Takeda
The Kirkland team was led by transactional partners Jacob Traff, Christopher Thomas, Michael Weed, Sanford Perl and David Higgins.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
